Impact of DuoTherm on Opioid Use and Chronic Low Back Pain
Study Details
Study Description
Brief Summary
Evaluate opioid use and pain change in chronic Low Back Pain with DuoTherm Compared to Sham
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
100 patients with chronic low back pain presenting for chiropractic and rehabilitation care will be stratified by gender and randomized to one of two conditions: a pain relief belt device incorporating multiple speeds of vibration and optional heat, cold, and pressure delivered through a sculpted metal plate; or a sham "posture plate" with a sculpted metal plate on a belt but no active heat, cold, pressure, or vibration. Patients will be prompted by a Qualtrics text link to a secure data recording site collecting pain and medication use.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: DuoTherm VibraCool Back Device A low back pain relief device incorporating multiple speeds and patterns of vibration and optional heat, cold, or pressure delivered through a sculpted metal plate attached with a belt and controlled by buttons on the belt. Patients will be instructed to use the device twice daily for 20 minutes. |
Device: Duotherm VibraCool Back Device
Active New multimodal pain device
Other Names:
|
Active Comparator: Multimodal TENS Unit LG SMART TENS stimulator is a portable electrotherapy device featuring transcutaneous electrical nerve stimulation (TENS) therapeutic device, which is used for pain relief. The stimulator sends a gentle electrical current to underlying nerves and muscle groups via electrodes applied on the skin. The parameters of the device are controlled by buttons on a controller with an adjustable intensity level. |
Device: TENS 8-channel unit
LG Smart TENS unit
|
Outcome Measures
Primary Outcome Measures
- Total Opioid use in morphine equivalent doses [6 months]
Daily diary of analgesic use and dose
- Change in opioid use in morphine equivalent doses [Difference between first 2 weeks and last 2 weeks over 6 month period]
Daily diary of analgesic use and dose
Secondary Outcome Measures
- Change in current weekly pain from initial to final [Weekly for 3 weeks, then monthly at 1,3, and 6 months]
Self-rated current pain on Numeric Rating Scale with 0 no pain and 11 maximum pain
- Change in 24 hour average pain weekly from initial to final [Weekly for 3 weeks, then monthly at 1,3, and 6 months]
Self-rated pain over past 24 hours on Numeric Rating Scale with 0 no pain and 11 maximum pain
- Change in Patient-Reported Outcomes Measurement Information System (PROMIS) Pain measures from initial to completion of study [Initial, 1 month, 3 months, completed at the end of 6 months]
Response formats for all scales are a 5-point ordinal rating scale of "Not at all," "A little bit," "Somewhat," "Quite a bit," and "Very much," where lower scores are better and higher scores indicate worse pain. The outcomes being addressed are Change in Monthly Pain Interference (8 questions, yielding possible scores of 8 (low) to 40 (highest), Pain Intensity (2 questions, yielding possible scores of 2(low) and 10 (highest), and Depression scores (4 questions, yielding possible scores of 4(low) and 20 (most depressed).
Other Outcome Measures
- Duotherm use [6 months]
Daily diary of study device or TENS unit
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Diagnosed with chronic low back pain by clinician
-
Pain duration >3 months with or without opioid prescription for this exacerbation
-
Self-report NRS measures >4
-
Capacity to understand all relevant risks and potential benefits of the study (informed consent)
-
Willingness to communicate information on prescription pill # and dose, or dose and pill type if medication is prescribed by someone else.
Exclusion Criteria:
-
Pacemaker
-
Radicular pain likely reflecting a surgical or mechanical problem
-
BMI greater than 30 (device won't fit)
-
Sensitivity to cold or vibration (e.g Raynaud's or Sickle Cell Disease)
-
Diabetic neuropathy rendering a patient unable to determine if the device is too hot
-
New neurologic deficits
-
Skin lesions over the low back area
-
Contraindication to any medication for pain management that would impact analgesic use record
-
Inability to apply DuoTherm or Sham Device
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Sport and Spine Rehab Clinics | Landover | Maryland | United States | 20785 |
2 | Sport and Spine Rehab Clinic | Fairfax | Virginia | United States | 22030 |
Sponsors and Collaborators
- MMJ Labs LLC
- Sport and Spine Rehab Clinical Research Foundation
Investigators
- Principal Investigator: Amy Baxter, MD, Pain Care Labs (a dba of MMJ Labs)
Study Documents (Full-Text)
None provided.More Information
Publications
- Cohen SP, Bhaskar A, Bhatia A, Buvanendran A, Deer T, Garg S, Hooten WM, Hurley RW, Kennedy DJ, McLean BC, Moon JY, Narouze S, Pangarkar S, Provenzano DA, Rauck R, Sitzman BT, Smuck M, van Zundert J, Vorenkamp K, Wallace MS, Zhao Z. Consensus practice guidelines on interventions for lumbar facet joint pain from a multispecialty, international working group. Reg Anesth Pain Med. 2020 Jun;45(6):424-467. doi: 10.1136/rapm-2019-101243. Epub 2020 Apr 3.
- Darnall BD, Colloca L. Optimizing Placebo and Minimizing Nocebo to Reduce Pain, Catastrophizing, and Opioid Use: A Review of the Science and an Evidence-Informed Clinical Toolkit. Int Rev Neurobiol. 2018;139:129-157. doi: 10.1016/bs.irn.2018.07.022. Epub 2018 Aug 6. Review.
- Davis CS, Lieberman AJ, Hernandez-Delgado H, Suba C. Laws limiting the prescribing or dispensing of opioids for acute pain in the United States: A national systematic legal review. Drug Alcohol Depend. 2019 Jan 1;194:166-172. doi: 10.1016/j.drugalcdep.2018.09.022. Epub 2018 Nov 3.
- Deyo RA, Dworkin SF, Amtmann D, Andersson G, Borenstein D, Carragee E, Carrino J, Chou R, Cook K, Delitto A, Goertz C, Khalsa P, Loeser J, Mackey S, Panagis J, Rainville J, Tosteson T, Turk D, Von Korff M, Weiner DK. Report of the NIH Task Force on research standards for chronic low back pain. Phys Ther. 2015 Feb;95(2):e1-e18. doi: 10.2522/ptj.2015.95.2.e1.
- Farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole MR. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001 Nov;94(2):149-158. doi: 10.1016/S0304-3959(01)00349-9.
- Furlan AD, Giraldo M, Baskwill A, Irvin E, Imamura M. Massage for low-back pain. Cochrane Database Syst Rev. 2015 Sep 1;(9):CD001929. doi: 10.1002/14651858.CD001929.pub3. Review.
- Maddalozzo GF, Kuo B, Maddalozzo WA, Maddalozzo CD, Galver JW. Comparison of 2 Multimodal Interventions With and Without Whole Body Vibration Therapy Plus Traction on Pain and Disability in Patients With Nonspecific Chronic Low Back Pain. J Chiropr Med. 2016 Dec;15(4):243-251. Epub 2016 Aug 25.
- Stumbo SP, Yarborough BJ, McCarty D, Weisner C, Green CA. Patient-reported pathways to opioid use disorders and pain-related barriers to treatment engagement. J Subst Abuse Treat. 2017 Feb;73:47-54. doi: 10.1016/j.jsat.2016.11.003. Epub 2016 Nov 15.
- DuoThermChronic